DIMENSIONAL FUND ADVISORS LP
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 354204
AUSTIN, TX
Position in ARCT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,487,283
-$738,817 QoQ
Shares Held
221,322
-23.2% QoQ
Ownership
0.779%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 133 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 79%
Shared 9%
None 12%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. ARCT ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ARCT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,487,283 | 221,322 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,226,100 | 288,355 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,006,327 | 490,429 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,236,278 | 555,414 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,575,448 | 582,279 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,530,152 | 616,634 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $12,004,644 | 707,404 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $18,396,244 | 792,600 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $22,358,703 | 918,222 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $37,275,998 | 1,103,820 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $34,333,960 | 1,088,930 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $24,881,686 | 973,843 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $19,928,411 | 694,854 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $11,664,303 | 486,621 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,136,521 | 302,861 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,121,007 | 143,118 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,351,428 | 149,392 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,865,741 | 217,572 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,773,492 | 74,939 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||